Surgery Center Guidance: Understanding Monoamine Oxidase Inhibitors

The following is written by Sheldon S. Sones, RPh, FASCP, President, Sheldon S. Sones and Associates.
 
Monoamine oxidase inhibitors (MAO inhibitors or MAOIs) are drugs which, by virtue of their pharmacological mechanisms of action, may lead to an exaggerated level of monoamines which can cascade into a hypertensive crisis.

Advertisement

 

It is a classic drug-drug and drug-food interaction that we must all be focused on as the consequences of co-administration with certain drugs can be catastrophic.

 

While the use of newer classes of antidepressants such as Prozac and Lexapro have curtailed the common use of MAOIs, they remain with us and may well be presented on a patient’s reconciliation drug list as a last line of treatment options. Further, some of the MAOIs fall into other drug categories.

 

Sign up for our FREE E-Weekly for more coverage like this sent to your inbox!

 

Suggested strategies:

  • Keep the current list of MAOIs easily accessible to your admitting staff.
  • Keep the list of potential interactions close at hand for review with the prescriber (i.e., anesthesia provider, surgeon, gastroenterologist who prescribes conscious sedation).

 

MAOI current list

Trade Name

Generic

Category

Parnate

Tranylcypromine Sulfate

Antidepressant

Marplan

Isocarboxazid

Antidepressant

Nardil

Phenelzine Sulfate

Antidepressant

Matulane

Procarbazine

Antineoplastic

Eutonyl

Pargyline

Antihypertensive

Eldepryl, Deprenyl

Selegiline

Antiparkinsonian

Azilect

Rasagiline

Antiparkinsonian

 

Common ambulatory surgery center drugs to avoid:

  • Ephedrine
  • All opiates but especially Demerol (meperidine)
  • Pseudoephedrine
  • Phenylephrine
  • Tramadol (Ultram)
  • Norepinephrine

 

Learn more about Sheldon S. Sones and Associates and www.sheldonsones.com.

 

More Articles Featuring Sheldon Sones:

4 Important Questions on Surgery Center Pharmacy and Safe Medication Practices

Perioperative Implications of Five Herbal Medications

6 Strategies for Surgery Centers to Address Drug Shortages

At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.

Register to Attend Webinar

Is ambulatory care healthcare’s big margin engine? 4 leaders weigh in

Wednesday, July 29
1:00 PM - 2:00 PM CDT

Presenters: Joe Ganley, athenahealthJeffrey Flynn, CASC, Gramercy Surgery CenterBryan Tsao, Access Center, Loma Linda University HealthJason Zepeda, Northridge Hospital Medical Center, CommonSpirit HealthGreg DeConciliis, PA-C, CASC, Boston Out­Patient Surgical Suites

Advertisement

Next Up in ASC Accreditation, Licensure & Medicare Certification

Advertisement

Comments are closed.